Aprea Therapeutics (APRE) Insider Trading & Ownership $3.35 +0.05 (+1.52%) (As of 11/14/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Aprea Therapeutics (NASDAQ:APRE) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage12.80%Number OfInsiders Buying(Last 12 Months)4Amount OfInsider Buying(Last 12 Months)$237,048.00Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$29,595.96 Get APRE Insider Trade Alerts Want to know when executives and insiders are buying or selling Aprea Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address APRE Insider Buying and Selling by Quarter Ad Crypto Swap Profits[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Aprea Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/23/2024Oren GiladCEOBuy500$3.92$1,960.00 10/18/2024Marc DueyDirectorSell6,462$4.58$29,595.96 10/16/2024Marc DueyDirectorBuy30,000$4.39$131,700.00 10/14/2024Marc DueyDirectorBuy190$2.58$490.20 10/14/2024Oren GiladCEOBuy1,000$2.59$2,590.00 10/11/2024Bernd R SeizingerDirectorBuy10,000$2.68$26,800.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 10/10/2024John P HamillCFOBuy450$2.61$1,174.50 10/10/2024Oren GiladCEOBuy150$2.54$381.00 3/13/2024Bernd R SeizingerDirectorBuy6,860$7.29$50,009.40 3/13/2024John P HamillCFOBuy1,010$7.29$7,362.90 3/13/2024Oren GiladCEOBuy2,000$7.29$14,580.00 (Data available from 1/1/2013 forward) APRE Insider Trading Activity - Frequently Asked Questions Who is on Aprea Therapeutics's Insider Roster? The list of insiders at Aprea Therapeutics includes Bernd R Seizinger, Eyal C Attar, Gregory Alan Korbel, John P Hamill, Marc Duey, and Oren Gilad. Learn more on insiders at APRE. What percentage of Aprea Therapeutics stock is owned by insiders? 12.80% of Aprea Therapeutics stock is owned by insiders. Learn more on APRE's insider holdings. Which Aprea Therapeutics insiders have been buying company stock? The following insiders have purchased APRE shares in the last 24 months: Bernd R Seizinger ($91,576.24), John P Hamill ($8,537.40), Marc Duey ($132,190.20), and Oren Gilad ($19,511.00). How much insider buying is happening at Aprea Therapeutics? Insiders have purchased a total of 56,228 APRE shares in the last 24 months for a total of $251,814.84 bought. Which Aprea Therapeutics insiders have been selling company stock? The following insider sold APRE shares in the last 24 months: Marc Duey ($29,595.96). How much insider selling is happening at Aprea Therapeutics? Insiders have sold a total of 6,462 Aprea Therapeutics shares in the last 24 months for a total of $29,595.96 sold. Aprea Therapeutics Key ExecutivesDr. Oren Gilad Ph.D. (Age 56)Co-Founder, CEO, President & Director Compensation: $796.95kMr. John P. Hamill CPA (Age 60)Senior VP, CFO, Principal Accounting Officer & Secretary Compensation: $610.23k1 recent tradesDr. Dansu Li Ph.D.Head of TechnologyDr. Lars B. Abrahmsen Ph.D. (Age 67)Senior VP & Chief Scientific Officer Mr. Brian Wiley (Age 56)Senior Vice President of Corporate Development & Strategy Dr. Michel Afargan Ph.D.Head of Pharmacology DevelopmentMr. Ze'ev Weiss B.Sc. (Age 62)C.P.A., Chief Business Advisor Dr. Nadeem Q. Mirza M.D.M.P.H., Chief Medical OfficerMs. Andrea EpsteinController More Insider Trading Tools from MarketBeat Related Companies ZIVO Insider Trading SYRS Insider Trading QNCX Insider Trading SPRO Insider Trading ALXO Insider Trading VNRX Insider Trading MNPR Insider Trading VOR Insider Trading VIRI Insider Trading DTIL Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking OnInsiders Are Buying High-Yielding Delek Logistics Partners This page (NASDAQ:APRE) was last updated on 11/15/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredTop "Sleeping Giant" Crypto In The Market NowTop "Sleeping Giant" Crypto In The Market Now We're looking at potential returns that could rewrite your fi...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aprea Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aprea Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free APRE Stock Alerts